Literature DB >> 34913895

Neoadjuvant Multimodality Induction Therapy for Locally Advanced Initially Unresectable Lung Cancer: A New Hope.

Alexander Sasha Krupnick1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 34913895      PMCID： PMC8816852          DOI： 10.1097/SLA.0000000000005343

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   13.787


× No keyword cloud information.
  11 in total

1.  Preoperative chemoradiotherapy for esophageal or junctional cancer.

Authors:  P van Hagen; M C C M Hulshof; J J B van Lanschot; E W Steyerberg; M I van Berge Henegouwen; B P L Wijnhoven; D J Richel; G A P Nieuwenhuijzen; G A P Hospers; J J Bonenkamp; M A Cuesta; R J B Blaisse; O R C Busch; F J W ten Kate; G-J Creemers; C J A Punt; J T M Plukker; H M W Verheul; E J Spillenaar Bilgen; H van Dekken; M J C van der Sangen; T Rozema; K Biermann; J C Beukema; A H M Piet; C M van Rij; J G Reinders; H W Tilanus; A van der Gaast
Journal:  N Engl J Med       Date:  2012-05-31       Impact factor: 91.245

2.  De novo design of potent and selective mimics of IL-2 and IL-15.

Authors:  Daniel-Adriano Silva; Shawn Yu; Umut Y Ulge; Jamie B Spangler; Kevin M Jude; Carlos Labão-Almeida; Lestat R Ali; Alfredo Quijano-Rubio; Mikel Ruterbusch; Isabel Leung; Tamara Biary; Stephanie J Crowley; Enrique Marcos; Carl D Walkey; Brian D Weitzner; Fátima Pardo-Avila; Javier Castellanos; Lauren Carter; Lance Stewart; Stanley R Riddell; Marion Pepper; Gonçalo J L Bernardes; Michael Dougan; K Christopher Garcia; David Baker
Journal:  Nature       Date:  2019-01-09       Impact factor: 49.962

3.  Cancer Statistics, 2021.

Authors:  Rebecca L Siegel; Kimberly D Miller; Hannah E Fuchs; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2021-01-12       Impact factor: 508.702

4.  A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907).

Authors:  Nobutoshi Ando; Hoichi Kato; Hiroyasu Igaki; Masayuki Shinoda; Soji Ozawa; Hideaki Shimizu; Tsutomu Nakamura; Hiroshi Yabusaki; Norio Aoyama; Akira Kurita; Kenichiro Ikeda; Tatsuo Kanda; Toshimasa Tsujinaka; Kenichi Nakamura; Haruhiko Fukuda
Journal:  Ann Surg Oncol       Date:  2011-08-31       Impact factor: 5.344

5.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.

Authors:  T N Walsh; N Noonan; D Hollywood; A Kelly; N Keeling; T P Hennessy
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

6.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

7.  Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database survey.

Authors:  Daniel Morgensztern; Shean Huey Ng; Feng Gao; Ramaswamy Govindan
Journal:  J Thorac Oncol       Date:  2010-01       Impact factor: 15.609

Review 8.  Immune Effects of Chemotherapy, Radiation, and Targeted Therapy and Opportunities for Combination With Immunotherapy.

Authors:  Jennifer A Wargo; Alexandre Reuben; Zachary A Cooper; Kevin S Oh; Ryan J Sullivan
Journal:  Semin Oncol       Date:  2015-06-03       Impact factor: 4.929

9.  Selective targeting of IL-2 to NKG2D bearing cells for improved immunotherapy.

Authors:  Reza Ghasemi; Eric Lazear; Xiaoli Wang; Saeed Arefanian; Alexander Zheleznyak; Beatriz M Carreno; Ryuji Higashikubo; Andrew E Gelman; Daniel Kreisel; Daved H Fremont; Alexander Sasha Krupnick
Journal:  Nat Commun       Date:  2016-09-21       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.